Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739349 · ClinicalTrials.gov registry record · Phase 2
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
A Phase 2 study, sponsored by Santen SAS.
- Completed
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
NCT00739349: Completed Phase 2 study, sponsored by Santen SAS.
NCT00739349 is a Phase 2 study that has completed, run by Santen SAS. The registered enrollment target is 132 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00739349, a Phase 2 study, has completed, sponsored by Santen SAS.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
Study Summary
Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and symptoms of dry eye after a 3 month treatment period.
Interventions
- DRUG NOVA22007 ''Cyclosporine''
- DRUG vehicle/placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
What the finished NCT00739349 record still lists
NCT00739349 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which NOVA22007 ''Cyclosporine'' is the first listed.
NCT00739349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00739349 about?
NCT00739349 is a clinical study titled "NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye". Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and symptoms of dry eye after a 3 month treatment period.
What is the current status of trial NCT00739349?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2008-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00739349?
The interventions under investigation include: NOVA22007 ''Cyclosporine'' (DRUG), vehicle/placebo (DRUG).
Who is sponsoring clinical trial NCT00739349?
This trial is sponsored by Santen SAS, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00739349's enrollment target sits among peer trials
132 539th of 2000 higher than 1,460 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia